Showing the single result

• 

  Cold pyridinine-related periodic syndrome (CAPS)

  Carnazumab

  【Product name】Ilaris

  [English common name]Canakinumab

  [Chinese common name]Carnazumab

  [English name]

  [Other Chinese names] Human anti-interleukin-1β monoclonal antibody, carnazumab

  [Indications] for active sexual whole body type 2 years old and abovearthritis(SJIA) treatment of patients for refractoryGouty arthritis.

  [Usage and Dosage] The recommended dosage of carnaximab is: adult (weight > 40 kg), subcutaneous injection of 150 mg per 8 weeks, and children (body weight 15 to 40 kg) subcutaneous injection of 2 mg · kg per 8 weeks. When the patient's efficacy is poor, the dose can be increased to 3 mg · kg.

  [Storage] The solution should be stored in the refrigerator at 2 to 8 ° C (36 to 46 ° F) and used within 4 hours.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.